| 摘要 |
The application provides a fusion protein comprising: (i) a polypeptide that comprises a sequence of amino acids residues selected from the group consisting of SEQ ID NOs: 83, 85, 87, 89, 95, 97, 103, 105, 111, 113, 139, 141, 143, 145, 147, 149, 151, 153, 155, 157, 159 and 161; and (ii) a polyalkyl oxide moiety. |
